Occlusal stabilization appliances: Evidence of their efficacy

Journal of the American Dental Association

Volumn 132, Issue 6, 2001, Pages 770-777

  Kreiner, Marcelo ^a   Betancor, Edwin ^a   Clark, Glenn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTHRALGIA; ARTICLE; BRUXISM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DENTAL EQUIPMENT; EPIDEMIOLOGY; EQUIPMENT DESIGN; FACE PAIN; HUMAN; MASTICATORY MUSCLE; META ANALYSIS; MUSCLE CONTRACTION; MUSCLE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STANDARD; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME;

ARTHRALGIA; BRUXISM; CONFOUNDING FACTORS (EPIDEMIOLOGY); EQUIPMENT DESIGN; FACIAL PAIN; HUMANS; MASTICATORY MUSCLES; MUSCLE CONTRACTION; MUSCULAR DISEASES; OCCLUSAL SPLINTS; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; TEMPOROMANDIBULAR JOINT DISORDERS; TREATMENT OUTCOME;

EID: 0035375798     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2001.0274     Document Type: Article

References (40)

1. Raphael K, Marbach JJ. Evidence-based care of musculoskeletal facial pain. Implications for the clinical science of dentistry. JADA 1997;128:73-9.
2. Lipton JA, Dionne RA. National Institutes of Health technology assessment conference on management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Endod 1997;83:49-183.
3. Dao TT, Lavigne GJ. Oral splints: the crutches for temporomandibular disorders and bruxism? Grit Rev Oral Biol Med 1998;9: 345-61.
4. White L, Tursky B, Schwartz GE. Placebo: Theory, research and mechanisms. New York: The Guilford Press; 1985.
5. Whitney CW, Von Korff M. Regression to the mean in treated versus untreated chronic pain. Pain 1992;50:281-5.
6. Beecher HK, Keats AS, Mosteller F. The effectiveness of oral analgesics (morphine, codeine, acetylsalicylic acid) and the problem of placebo 'reactors' and 'non-reactors.' J Pharmacol Exp Ther 1953; 109:393-400.
7. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994;271:1609-14.
8. Goodman P, Greene CS, Laskin DM. Response of patients with myofascial pain-dysfunction syndrome to mock equilibration. JADA 1976;92:755-8.
9. Pogge RC. The toxic placebo, Part I: side and toxic effects reported during the administration of placebo medicine. Med Times 1963;91: 773-8.
10. Blackwell B, Bloomfield SS, Buncher CR. Demonstration to medical students of placebo responses and non-drug factors. Lancet 1972; 1:1279-82.
11. Buckalew LW, Coffield KE. An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 1982;2:245-8.
12. Gleidman LH, Gantt W, Teitelbaum HA. Some implications of conditional reflex studies for placebo research. Am J Psychiatry 1957; 113:1103-7.
13. Ross S, Schnitzer SB. Further support for the placebo effect in the rat. Psychol Rep 1963;13:461-9.
14. Wikler A, Pescor FT, Miller D, Norrell H. Persistent potency of a secondary (conditioned) reinforcer following withdrawal of morphine from physically dependent rats. Psychopharmacologia 1971;20:103-17.
15. Knowles JB. Conditioning and the placebo effect: the effects of decaffeinated coffee on simple reaction time in habitual coffee drinkers. Behav Res Ther 1963;1:151-7.
16. Lang WJ, Rand MJ. A placebo response as a conditional reflex to glyceryl trinitrate. Med J Aust 1969;1:912-4.
17. Voudouris NJ, Peck CL, Coleman G. Conditioned placebo responses. J Pers Soc Psychol 1985;48:47-53.
18. Voudouris NJ, Peck CL, Coleman G. Conditioned response models of placebo phenomena: further support. Pain 1989;38:109-16.
19. Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain 1990;43:121-8.
20. Suchman AL, Ader R. Classic conditioning and placebo effects in crossover studies. Clin Pharmacol Ther 1992;52:372-7.
21. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999;19:484-94.
22. Smith TC, Thompson TL. The inherent, powerful therapeutic value of a good physician-patient relationship. Psychosomatics 1993; 4:166-70.
23. Thomas KB. General practice consultations: is there any point in being positive? B Med J 1987;294:1200-2.
24. WolfS. Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J Clin Invest 1950;29:100-9.
25. Dinnerstein AJ, Lowenthal M, Blitz B. The interaction of drugs with placebos in the control of pain and anxiety. Perspect Biol Med 1966;10:103-17.
26. Dinnerstein AJ, Halm J. Modification of placebo effects by means of drugs. J Abnorm Psychol 1970;75:308-14.
27. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: The essentials. 2nd ed. Baltimore: Williams & Wilkins; 1988:137.
28. Vahl CF, Osswald BR, Meinzer P, de Simone R, Thomas G, Hagl S. Internal quality assurance or Hawthorne effect? Langenbecks Arch Chir Suppl Kongressbd 1997;114:260-6.
29. Rheineck-Leyssius AT, Kalkman CJ, Trouwborst A. Influence of motivation of care providers on the incidence of postoperative hypoxaemia in the recovery room. Br J Anaesth 1996;77:453-7.
30. Campbell JP, Maxey VA, Watson WA. Hawthorne effect: implications for prehospital research. Ann Emerg Med 1995;26:590-4.
31. Greene CS, Laskin DM. Splint therapy for the myofascial pain: dysfunction syndrome: a comparative study. JADA 1972;84:624-8.
32. Dahlstrom L, Carlsson GE, Carlsson SG. Comparison of effects of electromyographic biofeedback and occlusal splint therapy on mandibular dysfunction. Scand J Dent Res 1982;90:151-6.
33. Okeson JP, Moody PM, Kemper JT, Haley JV. Evaluation of occlusal splint therapy and relaxation procedures in patients with temporomandibular disorders. JADA 1983;107:420-4.
34. Rubinoff MS, Gross A, McCall WP. Conventional and nonoccluding splint therapy compared for patients with myofascial pain dysfunction syndrome. Gen Dent 1987;35:502-6.
35. Johansson A, Wenneberg B, Wagersten C, Haraldson T. Acupuncture in treatment of facial muscular pain. Acta Odontol Scand 1991; 49:153-8.
36. List T, Helkimo M, Andersson S, Carlsson GE. Acupuncture and occlusal splint therapy in the treatment of craniomandibular disorders. Swed Dent J 1992;16:125-41.
37. Turk DC, Zaki HS, Rudy TE. Effects of intraoral appliance and biofeedback/stress management alone and in combination in treating pain and depression in patients with temporomandibular disorders. J Prosthet Dent 1993;70:158-64.
38. Wright E, Anderson G, Schulte J. A randomized clinical trial of intraoral soft splints and palliative treatment for masticatory muscle pain. J Orofac Pain 1995;9:192-9.
39. Ekberg EC, Vallon D, Nilner M. Occlusal appliance therapy in patients with temporomandibular disorders: a double-blind controlled study in a short-term perspective. Acta Odontol Scand 1998;56:122-8.
40. Dao TT, Lavigne GJ, Charbonneau A, Feine JS, Lund JP. The efficacy of oral splints in the treatment of myofascial pain of the jaw muscles: a controlled clinical trial. Pain 1994;56:85-94.